» Articles » PMID: 23765162

Highly Efficient Selection of Epitope Specific Antibody Through Competitive Yeast Display Library Sorting

Overview
Journal MAbs
Date 2013 Jun 15
PMID 23765162
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Combinatory antibody library display technologies have been invented and successfully implemented for the selection and engineering of therapeutic antibodies. Precise targeting of important epitopes on the protein of interest is essential for such isolated antibodies to serve as effective modulators of molecular interactions. We developed a strategy to efficiently isolate antibodies against a specific epitope on a target protein from a yeast display antibody library using dengue virus envelope protein domain III as a model target. A domain III mutant protein with a key mutation inside a cross-reactive neutralizing epitope was designed, expressed, and used in the competitive panning of a yeast display naïve antibody library. All the yeast display antibodies that bound to the wild type domain III but not to the mutant were selectively sorted and characterized. Two unique clones were identified and showed cross-reactive binding to envelope protein domain IIIs from different serotypes. Epitope mapping of one of the antibodies confirmed that its epitope overlapped with the intended neutralizing epitope. This novel approach has implications for many areas of research where the isolation of epitope-specific antibodies is desired, such as selecting antibodies against conserved epitope(s) of viral envelope proteins from a library containing high titer, high affinity non-neutralizing antibodies, and targeting unique epitopes on cancer-related proteins.

Citing Articles

Modular binder technology by NGS-aided, high-resolution selection in yeast of designed armadillo modules.

Stark Y, Menard F, Jeliazkov J, Ernst P, Chembath A, Ashraf M Proc Natl Acad Sci U S A. 2024; 121(27):e2318198121.

PMID: 38917007 PMC: 11228518. DOI: 10.1073/pnas.2318198121.


Epitope binning for multiple antibodies simultaneously using mammalian cell display and DNA sequencing.

Lin N, Miyamoto K, Ogawara T, Sakurai S, Kizaka-Kondoh S, Kadonosono T Commun Biol. 2024; 7(1):652.

PMID: 38806676 PMC: 11133372. DOI: 10.1038/s42003-024-06363-7.


Guidelines, Strategies, and Principles for the Directed Evolution of Cross-Reactive Antibodies Using Yeast Surface Display Technology.

Linciano S, Wong E, Mazzocato Y, Chinellato M, Scaravetti T, Caregnato A Methods Mol Biol. 2022; 2491:251-262.

PMID: 35482195 DOI: 10.1007/978-1-0716-2285-8_14.


Engineered protein-small molecule conjugates empower selective enzyme inhibition.

Lewis A, Harthorn A, Johnson S, Lobb R, Hackel B Cell Chem Biol. 2021; 29(2):328-338.e4.

PMID: 34363759 PMC: 8807807. DOI: 10.1016/j.chembiol.2021.07.013.


An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella infections.

Sierocki R, Jneid B, Orsini Delgado M, Plaisance M, Maillere B, Nozach H PLoS Negl Trop Dis. 2021; 15(3):e0009231.

PMID: 33711056 PMC: 7990167. DOI: 10.1371/journal.pntd.0009231.


References
1.
Zhang M, Choudhry V, Sidorov I, Tenev V, Vu B, Choudhary A . Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning. J Immunol Methods. 2006; 317(1-2):21-30. PMC: 1805821. DOI: 10.1016/j.jim.2006.09.016. View

2.
Guzman M, Hermida L, Bernardo L, Ramirez R, Guillen G . Domain III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines. 2010; 9(2):137-47. DOI: 10.1586/erv.09.139. View

3.
Sukupolvi-Petty S, Austin S, Engle M, Brien J, Dowd K, Williams K . Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol. 2010; 84(18):9227-39. PMC: 2937608. DOI: 10.1128/JVI.01087-10. View

4.
Shrestha B, Brien J, Sukupolvi-Petty S, Austin S, Edeling M, Kim T . The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 2010; 6(4):e1000823. PMC: 2848552. DOI: 10.1371/journal.ppat.1000823. View

5.
Arnaout R, Lee W, Cahill P, Honan T, Sparrow T, Weiand M . High-resolution description of antibody heavy-chain repertoires in humans. PLoS One. 2011; 6(8):e22365. PMC: 3150326. DOI: 10.1371/journal.pone.0022365. View